Myofascial pain syndrome in infraspinatus muscle post needling soreness myofascial pain syndrome infraspinatus muscle
Conditions
Interventions
cold air therapy using the Cryo AIR mini cold air blower, device serial number 160311378. This device draws in ambient air and cools it using a compressor to a temperature of -32 degrees Celsius. The
Experimental Device,Active Comparator Device
Cold air therapy,Cold pack
Sponsors
Phramongkutklao foundation
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Aged 20 years or older 2.Diagnosed with Myofascial Pain Syndrome (MPS) in the infraspinatus muscle and received dry needling treatment in the infraspinatus muscle 3.Experiencing post-needling soreness in the infraspinatus muscle, with a pain level of 4 or above on the Numerical Rating Scale (NRS), indicating moderate pain 4.Voluntarily agrees to participate in the research study and receive treatment for post-needling soreness, and has signed the informed consent form for participation in the study
Exclusion criteria
Exclusion criteria: 1.Contraindications to the use of cold air therapy or cold pack compresses such as open wounds or injuries at the treatment site within the past 6 months, bleeding disorders in the neck and shoulder area, cold allergy, history of cold induced urticaria or hypersensitivity reactions to cold, intolerance to cold, history of Raynaud Disease or Raynaud Phenomenon, cryoglobulinemia, paroxysmal cold hemoglobinuria, peripheral vascular disease, or unstable circulatory conditions, especially in the infraspinatus muscle area 2.Presence of other underlying medical conditions as documented in the medical records that may affect neck and shoulder pain, including fibromyalgia, cervical disc herniation, cervical spinal stenosis, cervical radiculopathy, cervical myelopathy, history of surgery in the neck or shoulder region, history of injury in the neck or shoulder within the past 6 months, or existing shoulder pathology 3.History of taking pain-relief or anti-inflammatory medications (NSAIDs) within the past 24 hours 4.Cognitive impairments, inability to cooperate, or any conditions that prevent accurate self-reporting or assessment of pain 5.Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post needling soreness 0 and 10 minutes after intervention Numerical Rating Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect 0 and 10 minutes after intervention Patient reported event using a questionnaire interview,Skin Temperature immediately after intervention use TP500 medical infrared thermometer | — |
Countries
Thailand
Contacts
Public ContactThanchanok Ucharattana
Phramongkutklao Hospital
Outcome results
None listed